Palmar-Plantar Erythrodysesthesia in Patients Receiving Capecitabine and Intratumor Thymidine Phosphorylase and Dihydropyrimidine Dehydrogenase: Is There a Pharmacologic Explanation?
- 30 September 2007
- journal article
- Published by Elsevier BV in Supportive Cancer Therapy
- Vol. 4 (4), 211-218
- https://doi.org/10.3816/sct.2007.n.017
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Antitumor Efficacy of Capecitabine and Celecoxib in Irradiated and Lead-Shielded, Contralateral Human BxPC-3 Pancreatic Cancer Xenografts: Clinical Implications of Abscopal EffectsClinical Cancer Research, 2005
- Phase I Study of Capecitabine With Concomitant Radiotherapy for Patients With Locally Advanced Pancreatic Cancer: Expression Analysis of Genes Related to OutcomeJournal of Clinical Oncology, 2005
- Capecitabine Versus Continuous-Infusion 5-Fluorouracil for Colorectal Cancer: A Retrospective Efficacy and Safety ComparisonClinical Colorectal Cancer, 2005
- A Physiologically Based Pharmacokinetic Analysis of Capecitabine, a Triple Prodrug of 5-FU, in Humans: The Mechanism for Tumor-Selective Accumulation of 5-FUPharmaceutical Research, 2001
- Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patientsCancer Chemotherapy and Pharmacology, 2000
- Quantitation of Dihydropyrimidine Dehydrogenase Expression by Real-Time Reverse Transcription Polymerase Chain ReactionAnalytical Biochemistry, 2000
- CapecitabineDrugs, 1999
- Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissueEuropean Journal of Cancer, 1998
- Tumor angiogenesis and expression of thymidine phosphorylase/ platelet derived endothelial cell growth factor in human gastric carcinomaCancer Letters, 1996
- Metabolism of pyrimidine analogues and their nucleosidesPharmacology & Therapeutics, 1990